John A. Bouranis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
John A. Bouranis has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Carmen P. Wong
Skeletal Biology Laboratory, School of Nutrition and Public Health, Oregon State University, Corvallis, OR 97331, USA
1 shared publication - Emily Ho
Linus Pauling Institute, Oregon State University, Corvallis, OR, United States
1 shared publication - Jackilen Shannon
Oregon Health & Science University
1 shared publication - Zhenzhen Zhang
Oregon Health & Science University
1 shared publication
Latest Publications
- Open Access
- 21 August 2025
- Published by Annual Reviews in Annual Review of Nutrition
- Vol. 45 (1) , 171-195
Cruciferous Vegetables, Bioactive Metabolites, and Microbiome for Breast Cancer Prevention
Breast cancer is a heterogeneous disease with varying subtypes, prognoses, and treatment responses. Cruciferous vegetables have shown promise in reducing breast cancer risk. This review discusses ( a ) the efficacy of sulforaphane (SFN) and indole-3-carbinol (I3C)/3,3′-diindolylmethane (DIM) on breast cancer risk, prognosis, and treatment outcomes in recent human studies through 2024; ( b ) preclinical studies (2018–2024) that evaluate the efficacy and synergism of SFN, DIM, and other phytochemicals with conventional breast cancer treatments as promising combination therapy strategies for validation in future clinical trials; and ( c ) the role of the microbiome in breast cancer and the interaction between interindividual variations in gut microbiome and glucosinolate metabolism that could modify the benefits of cruciferous vegetable consumption and breast cancer treatment efficacy. Integrating cruciferous vegetables and their bioactive compounds in light of an individual's microbiome profile as a complementary approach alongside standard treatments is a promising strategy in breast cancer care.
- 21 August 2025
- Published by Annual Reviews in Annual Review of Nutrition
- Vol. 45 (1) , 171-195
Open AccessCruciferous Vegetables, Bioactive Metabolites, and Microbiome for Breast Cancer Prevention
Breast cancer is a heterogeneous disease with varying subtypes, prognoses, and treatment responses. Cruciferous vegetables have shown promise in reducing breast cancer risk. This review discusses ( a ) the efficacy of sulforaphane (SFN) and indole-3-carbinol (I3C)/3,3′-diindolylmethane (DIM) on breast cancer risk, prognosis, and treatment outcomes in recent human studies through 2024; ( b ) preclinical studies (2018–2024) that evaluate the efficacy and synergism of SFN, DIM, and other phytochemicals with conventional breast cancer treatments as promising combination therapy strategies for validation in future clinical trials; and ( c ) the role of the microbiome in breast cancer and the interaction between interindividual variations in gut microbiome and glucosinolate metabolism that could modify the benefits of cruciferous vegetable consumption and breast cancer treatment efficacy. Integrating cruciferous vegetables and their bioactive compounds in light of an individual's microbiome profile as a complementary approach alongside standard treatments is a promising strategy in breast cancer care.